The latest closing stock price for Seres Therapeutics as of November 22, 2024 is 0.77.
An investor who bought $1,000 worth of Seres Therapeutics stock at the IPO in 2015 would have $-985 today, roughly -1 times their original investment - a -37.31% compound annual growth rate over 9 years.
The all-time high Seres Therapeutics stock closing price was 51.40 on June 26, 2015.
The Seres Therapeutics 52-week high stock price is 2.05, which is 166.2% above the current share price.
The Seres Therapeutics 52-week low stock price is 0.54, which is 29.9% below the current share price.
The average Seres Therapeutics stock price for the last 52 weeks is 0.96.
An investor who bought $1,000 worth of Seres Therapeutics stock at the IPO in 2015 would have $-985 today, roughly -1 times their original investment - a -37.31% compound annual growth rate over 9 years.
The all-time high Seres Therapeutics stock closing price was 51.40 on June 26, 2015.
The Seres Therapeutics 52-week high stock price is 2.05, which is 166.2% above the current share price.
The Seres Therapeutics 52-week low stock price is 0.54, which is 29.9% below the current share price.
The average Seres Therapeutics stock price for the last 52 weeks is 0.96.